fres

Fresenius Medical Care North America (FMCNA) is a premier healthcare company focused on providing the highest quality care to people with renal and other chronic conditions. Our customers, individuals living with kidney failure and other chronic illnesses, face significant challenges in managing their health and maintaining their quality of life. That is why we strive to be the partner of choice by leading the way with collaborative, entrepreneurial new models of value-based care that take full responsibility for the patients we serve while reducing costs and improving outcomes. This approach allows us to coordinate healthcare services at pivotal care points for hundreds of thousands of chronically ill people and enhance the lives of those trusted to our care.

Through our industry-leading network of Fresenius Kidney Care dialysis facilities, outpatient cardiac and vascular labs, and urgent care centers, we provide coordinated healthcare services for hundreds of thousands of people living with kidney disease throughout the continent. As the world's largest fully integrated renal company, FMCNA's Renal Therapies Group manufactures and distributes the most comprehensive line of dialysis equipment, disposable products, and renal pharmaceuticals. We also offer specialty pharmacy and laboratory services. Our integrated network includes more than 2,200 dialysis centers nationwide, in addition to outpatient vascular labs and urgent care centers; the country's largest practice of hospitalists, intensive and emergency care; a specialty pharmacy and laboratory; and a manufacturing and distribution division. The scope and sophistication of this vertically integrated network provide us with seamless oversight of our patients' entire care continuum. With an unmatched ability to analyze immense amounts of clinical data from within our own care ecosystem, FMCNA maintains a world-class research network encompassing more than 200 principal investigators across 250 dialysis research sites, with access to more than 190,000 active ESRD patients and 390,000 active CKD patients. The ability to champion data-driven care innovations remains one of the company's key competitive advantages, informing every aspect of patient care and experience, quality improvement programs, coordinated care delivery, and care integration. Our mission is to deliver superior care that improves the quality of life of every patient, every day, setting the standard by which others in the healthcare industry are judged.